A business in context
PFE research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-25 | Buckley Mortimer J | A · Grant / award | Phantom Stock Units | 1307.99 | 28.67 |
| 2026-09-25 | Echevarria Joseph | A · Grant / award | Phantom Stock Units | 1613.19 | 28.67 |
| 2026-09-25 | NARAYEN SHANTANU | A · Grant / award | Phantom Stock Units | 1743.98 | 28.67 |
| 2026-09-25 | Quincey James | A · Grant / award | Phantom Stock Units | 1351.59 | 28.67 |
| 2026-09-25 | SMITH JAMES C | A · Grant / award | Phantom Stock Units | 1569.59 | 28.67 |
| 2026-09-25 | Taraporevala Cyrus | A · Grant / award | Phantom Stock Units | 1307.99 | 28.67 |
| 2026-09-15 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 22.0 | 27.55 |
| 2026-08-31 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 21.0 | 28.46 |
| 2026-08-14 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 22.0 | 26.79 |
| 2026-08-12 | BOURLA ALBERT | P · Purchase | Common Stock | 38000.0 | 26.34 |
| 2026-08-05 | DAMICO JENNIFER B. | S · Sale | Common Stock | 3278.0 | 25.4 |
| 2026-08-05 | BLAYLOCK RONALD E | P · Purchase | Common Stock | 39231.0 | 25.46 |
| 2026-08-05 | Buckley Mortimer J | P · Purchase | Common Stock | 37632.0 | 25.52 |
| 2026-07-31 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 24.0 | 25.01 |
| 2026-07-15 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 24.0 | 24.82 |
| 2026-07-09 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 84.0 | 24.25 |
| 2026-06-30 | BOURLA ALBERT | A · Grant / award | Phantom Stock Units SSP | 25.0 | 24.08 |
Identity & relationships
SEC issuer · 0000078003PFIZER INC
G. D. Searle & CompanyPfizer UKWyethPfizer (Japan)Pfizer AktiebolagPfizer (Canada)Pfizer SASPfizer Corporation Austria Gesellschaft mbHPfizer SLPfizer S.R.L.Pfizer (Australia)Pfizer en SuisseWarner–LambertAgouron PharmaceuticalsParke-DavisHospiraPfizer AGPfizer, spol. s r.o.
- Legal Entity Identifier
- 765LHXWGK1KXCLTFYQ30
- GLEIF legal name
- PFIZER INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-03-19T12:44:11Z
Search names and former names
View Wikidata identity and references ↗
- Pfizer · alias · wikidata
- PFE · alias · wikidata
- G. D. Searle & Company · subsidiary · wikidata
- G. D. Searle and Company · subsidiary · wikidata
- G. D. Searle & Co. · subsidiary · wikidata
- Searle & Co. · subsidiary · wikidata
- Searle · subsidiary · wikidata
- Pfizer UK · subsidiary · wikidata
- Pfizer Limited · subsidiary · wikidata
- Wyeth · subsidiary · wikidata
- Wyeth Pharmaceuticals Inc. · subsidiary · wikidata
- Pfizer (Japan) · subsidiary · wikidata
- Pfizer Aktiebolag · subsidiary · wikidata
- Pfizer AB · subsidiary · wikidata
- Pfizer (Canada) · subsidiary · wikidata
- Pfizer SAS · subsidiary · wikidata
- Pfizer Corporation Austria Gesellschaft mbH · subsidiary · wikidata
- Pfizer Corporation Austria Ges.mbH · subsidiary · wikidata
- Pfizer Corporation Austria GmbH · subsidiary · wikidata
- Pfizer SL · subsidiary · wikidata
- Pfizer S.L. · subsidiary · wikidata
- Pfizer S.A. · subsidiary · wikidata
- Pfizer S.R.L. · subsidiary · wikidata
- Pfizer SRL · subsidiary · wikidata
- Pfizer (Australia) · subsidiary · wikidata
- Pfizer en Suisse · subsidiary · wikidata
- PFIZER PFE SWITZERLAND GMBH, Pfizer in Switerzland · subsidiary · wikidata
- Warner–Lambert · subsidiary · wikidata
- Warner-Lambert Inc · subsidiary · wikidata
- Warner-Lambert-House · subsidiary · wikidata
- Lambert Pharmacal Co. · subsidiary · wikidata
- Lambert Pharmacal · subsidiary · wikidata
- Lambert Pharmacal Company · subsidiary · wikidata
- Agouron Pharmaceuticals · subsidiary · wikidata
- Agouron Pharmaceuticals, Inc. · subsidiary · wikidata
- Parke-Davis · subsidiary · wikidata
- Parke, Davis & Company · subsidiary · wikidata
- Hospira · subsidiary · wikidata
- Hospira, Inc. · subsidiary · wikidata
- Pfizer AG · subsidiary · wikidata
- Pfizer SA · subsidiary · wikidata
- Pfizer, spol. s r.o. · subsidiary · wikidata
- Pfizer spol sro · subsidiary · wikidata
- Pfizer, spol. s.r.o · subsidiary · wikidata
- Pfizer (Czech Republic) · subsidiary · wikidata
- PFIZER INC · former SEC name · 1994-03-18 to 2026-10-16
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $63.63B | $68.34B |
| 2023-12-31 | $59.55B | $65.85B |
| 2022-12-31 | $101.17B | $116.47B |
| 2021-12-31 | $81.29B | $101.06B |
| 2020-12-31 | $41.65B | $54.22B |
| 2019-12-31 | $40.91B | $53.91B |
| 2018-12-31 | $40.83B | $54.78B |
| 2017-12-31 | $52.55B | $72.23B |